article thumbnail

Clinical Trial: Cannabinoid Administration Via a Metered-Dose Inhaler Is Safe and Effective for Chronic Pain Patients

NORML

A team of Israeli researchers conducted a randomized placebo-controlled clinical trial to assess the safety and efficacy of a novel, metered-dose cannabis inhaler in 27 patients with chronic pain. Chronic pain is the most commonly reported qualifying condition among medical cannabis patients enrolled in state-specific access programs.

article thumbnail

Veterans Medical Marijuana Access Legislation Introduced In House and Senate

NORML

Today, Senator Brian Schatz (D-HI) and Representative Barbara Lee (D-CA) introduced legislation, The Veterans Medical Marijuana Safe Harbor Act , to expand and facilitate medical cannabis access to military veterans suffering from chronic pain, PTSD, and other serious medical conditions.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Study: Daily Cannabis Use Among Pain Patients Associated with Less Non-Prescription Opioid Use

NORML

Patients suffering from persistent pain conditions who frequently use cannabis are far less likely to use non-prescription opioids, according to longitudinal data published in the journal PLOS One. Authors reported “an independent negative association between frequent cannabis use and frequent illicit opioid use.” ’

article thumbnail

Studies: Medical Cannabis Enrollees Typically Reduce Their Use of Opioids

NORML

Patients diagnosed with chronic pain and other debilitating conditions typically reduce, or in some cases, eliminate their use of opioids following their enrollment in state-sanctioned medical cannabis access programs. Several peer-reviewed studies now document this trend. percent versus 44.8 percent versus 3.4

article thumbnail

Patients Frequently Substituting Cannabis For Anti-Anxiety Drugs

NORML

According to data compiled by the US Centers for Disease Control, the drug was attributed to over 11,500 overdose deaths in 2017. In the first study , Canadian researchers assessed the relationship between cannabis and benzodiazepines in a cohort of 146 patients enrolled in the nation’s medical marijuana access program.

Patients 239
article thumbnail

Patient Stories: How MMJ is Changing Lives in West Virginia

MMJ Recs

Cannabis Therapy Impact on West Virginia Patients Medical marijuana was legalized in West Virginia in 2017, and since then, it has been offering a glimmer of hope to many residents suffering from various medical conditions. One of the most significant impacts of MMJ in West Virginia is in the realm of pain management.

article thumbnail

The Latin American Cannabis Landscape – Part Two: Regulated Markets and Patient Access

CannaTech

Medical cannabis continued to pop up across the region year after year: imports in Brazil began in 2014, trials started in Chile in 2014, regulations were implemented in Colombia and Jamaica in 2015, the same followed in the Cayman Islands and parts of Argentina in 2016, Paraguay in 2017, and the list carries on from 2018 to date.

Access 89